LAUREN SNYDER: Open Payments
NPI 1013568104 · AUSTELL, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,404 in 155 payments from 45 companies in 2025. Trend: 2023 $1,443 · 2024 $3,417 · 2025 $3,404
Food & beverage: $3,391Education: $13
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 19 | $338 |
| Merck Sharp & Dohme LLC | 10 | $276 |
| Novartis Pharmaceuticals Corporation | 10 | $247 |
| AstraZeneca Pharmaceuticals LP | 9 | $246 |
| Genentech USA, Inc. | 8 | $176 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $174 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $165 |
| ABBVIE INC. | 7 | $151 |
| Daiichi Sankyo Inc. | 6 | $136 |
| SOBI, INC | 4 | $104 |
Products named: KEYTRUDA, Nubeqa, Enhertu, PADCEV, VENCLEXTA, LONSURF, IBRANCE, EPKINLY.
Industry payments across GA — which companies pay providers there.
